Executives from UnitedHealth Group (NYSE: UNH) and Amedisys (NASDAQ: AMED) reportedly will meet with U.S. Justice Department officials in an effort to seal their pending deal. Amedisys has indicated that it expects the deal to close in Q4. However, the Justice Department (DOJ) has been making inquiries into the transaction and reportedly has been considering […]
Private equity firms in the hospice space are adapting their “roll-up” strategies as economic uncertainties persist. Roll ups are a common approach to private equity investment. This occurs when a firm buys a larger platform company and then gradually acquires smaller organizations to foster growth. But in 2023, deal volume slowed across the board. While […]
Regulatory attention heating up in the hospice industry could be impacting buyers’ mergers and acquisitions decisions. Nuances in the regulatory environment can be difficult to navigate, perhaps more so for private equity and venture capital investors that are new to the industry. Changes to federal enforcement practices during the next year could bring some additional […]
Developments in a False Claims Act (FCA) suit involving Curo Health Services signal that mounting a defense may become more complicated for accused hospices. Regulators and investigators have sharpened their gaze on alleged False Claims Act violations by hospice providers, as well as the closely related anti-kickback statute, sometimes resulting in multi-million settlements. These cases […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
